These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878. Wadler S; Yeap B; Vogl S; Carbone P Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766 [TBL] [Abstract][Full Text] [Related]
3. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)]. de Gramont A; Drolet Y; Louvet C; Dray C; Krulik M; Pigné A; Lavoie A; Painchaud M; Blouin R; Tessier C J Gynecol Obstet Biol Reprod (Paris); 1986; 15(1):105-9. PubMed ID: 3084619 [TBL] [Abstract][Full Text] [Related]
5. Modulation and intensification of a cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin ovarian cancer regimen. Bruckner HW; Cohen CJ; Feuer E; Holland JF Obstet Gynecol; 1989 Mar; 73(3 Pt 1):349-56. PubMed ID: 2492648 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of advanced ovarian cancer]. de Gramont A; Krulik M; Pigne A; Brissaud P; Sirinelli A; Hubert D; Zylberait D; Debray J Sem Hop; 1984 Mar; 60(14):957-60. PubMed ID: 6326283 [TBL] [Abstract][Full Text] [Related]
8. Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin. Pater JL; Carmichael JA; Krepart GV; Fraser RC; Roy M; Kirk ME; Levitt M; Brown LB; Wilson KS; Shelley WE Cancer Treat Rep; 1987 Mar; 71(3):277-81. PubMed ID: 3102056 [TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials. Thigpen T; Vance R; Puneky L; Khansur T Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816 [TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patients. Brower MS; Coleman M; Pasmantier MW; Silver RT; Mamaril AP; Quiguyan CC Med Pediatr Oncol; 1984; 12(1):17-24. PubMed ID: 6321930 [TBL] [Abstract][Full Text] [Related]
11. Phase II trial of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-dichlorodiammineplatinum(II) combination chemotherapy in advanced ovarian carcinoma. Kane R; Harvey H; Andrews T; Bernath A; Curry S; Dixon R; Gottlieb R; Kukrika M; Lipton A; Mortel R; Ricci J; White D Cancer Treat Rep; 1979 Feb; 63(2):307-9. PubMed ID: 109201 [TBL] [Abstract][Full Text] [Related]
12. The role of hexamethylmelamine in the management of ovarian cancer. Schein PS; Scheffler B; McCulloch W Cancer Treat Rev; 1991 Mar; 18 Suppl A():67-75. PubMed ID: 1904311 [TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results. Sessa C; Colombo N; Bolis G; Marsoni S; Mangioni C Cancer Treat Rev; 1991 Mar; 18 Suppl A():37-46. PubMed ID: 1904308 [No Abstract] [Full Text] [Related]
14. Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma. Richman CM; Podczaski E; Weiser PA; Herbst AL Oncology; 1986; 43(1):12-7. PubMed ID: 3079898 [TBL] [Abstract][Full Text] [Related]
15. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience. Cohen CJ; Bruckner HW; Goldberg JD; Holland JF Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114 [No Abstract] [Full Text] [Related]
16. Combination chemotherapy with or without hexamethylmelamine in alkylating-agent resistant ovarian carcinoma. Neijt JP; ten Bokkel Huinink WW; van der Burg ME; van Oosterom AT; Kooyman CD; van Houwelingen JC; Pinedo HM Cancer; 1984 Apr; 53(7):1467-72. PubMed ID: 6421472 [TBL] [Abstract][Full Text] [Related]
17. Treatment of ovarian cancer with a combination of cis-platinum, adriamycin, cyclophosphamide and hexamethylmelamine. Razis DV; Poulakou E; Petounis A; Papadimitriou G; Kosmides P; Delides G Oncology; 1982; 39(4):205-8. PubMed ID: 6806735 [TBL] [Abstract][Full Text] [Related]
18. Adriamycin and cis-platinum in advanced ovarian cancer. de Gramont A; Drolet Y; Lavoie A; Painchaud M; Blouin R; Tessier C; Ouellet P Eur J Cancer Clin Oncol; 1985 Jun; 21(6):665-9. PubMed ID: 4040466 [TBL] [Abstract][Full Text] [Related]